Clinical Trials Directory

Trials / Completed

CompletedNCT04108910

Morbidity Rate for UTI Through Use of PCR-Based Diagnosis and Management

Reduction in Morbidity Rate for Urinary Tract Infections Through Use of PCR-Based Diagnosis and Management

Status
Completed
Phase
Study type
Observational
Enrollment
66,381 (actual)
Sponsor
Pathnostics · Industry
Sex
All
Age
18 Years – 111 Years
Healthy volunteers

Summary

This retrospective study is to determine if the use of PCR for detection and identification of pathogens in UTI along with antimicrobial susceptibility information, affords more efficacious treatment of UTI, as compared to traditional urine culture for patients served by House Call Physicians.

Detailed description

The objective of this study is to determine if retrospective data will show that use of PCR for detection and identification of pathogens in UTI, and antimicrobial susceptibility information, affords more efficacious treatment of UTI, thereby reducing UTI-related morbidity and costs in a patient population that is served by House Call Physicians. House call physicians attend elderly and other adults patients who are suffering from illness or chronic conditions in the safety, privacy, and comfort of their home or assisted living location. In making house calls, physicians ease the burden and difficulty of these chronic patients from traveling to the doctor's office.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTGuidance UTI

Timeline

Start date
2016-03-01
Primary completion
2019-07-01
Completion
2020-04-01
First posted
2019-09-30
Last updated
2024-04-03

Source: ClinicalTrials.gov record NCT04108910. Inclusion in this directory is not an endorsement.